The size of the North America Tangential Flow Filtration Market is valued worth USD 277.22 Million in 2022 and is forecasted to grow at a CAGR of 10.5% to reach USD 456.71 Million by 2027 during the forecast period.
The pharmaceuticals industry primarily drives the expansion of the North American tangential flow filtration market. The advantages of tangential flow filtration over standard flow filtration, the expanding use of single-use technology, and cGMP adoption are all discussed.
Furthermore, the market is estimated to grow due to increasing investment from pharmaceutical companies, increasing acceptance of single-use technologies, and the advantages of tangential flow filtration. A growth in biologics manufacture, investments by big pharmaceutical firms and CMOs in expanded facilities to fulfill rising biologics demand, and a requirement for efficient and cost-effective downstream processing technologies in bio-manufacturing are the key drivers driving this market.
Tangential flow filtration separates and purifies a wide range of biomolecules, including antibodies, nucleic acids, and recombinant proteins. This approach has various advantages, including the ability to be employed in various biological domains, such as immunology, protein chemistry, molecular biology, biochemistry, and microbiology, and its adaptability to a variety of volumes.
Throughout the forecast period, breakthrough solutions such as disposable technologies have the potential to significantly accelerate the growth of the North American tangential flow filtration market. In addition, flexible and productive manufacturing facility designs that allow for low-cost scale upgrades in a smaller footprint are in high demand because of the present market conditions.
The significant capital expenditure necessary to establish new manufacturing facilities, on the other hand, is a key stumbling block to the market's progress in North America. Furthermore, competing technologies such as centrifugation, direct flow filtration, and pre-coat filtering are expected to hamper the market.
Compared to tangential flow filtration, diatomaceous earth filtration (DE) and sheets have quicker flow rates. However, replacing a module comes at a high cost. Filtration is a less regulated process. Smaller units have flow rates between 150 and 350 gallons per hour. The start-up cost per person is around $25,000.00. It is tough to compare vendors. With bigger units, up to 15,000 GPH may be produced. Filters can be added or removed as needed.
This research report on the North America Tangential Flow Filtration Market has been segmented and sub-segmented into the following categories.
By Membrane Material:
By pore size:
Geographically, North America holds the market with the largest share, accounting for the bulk of the claim in tangential flow filtration over the period due to an expansion in the biopharmaceutical industry and the growing adoption of single-use technologies.
The U.S Tangential Flow Filtration Market is the most important contributor to market dominance with a significant portion of the industry. Factors such as several essential players and large pharmaceutical and biopharmaceutical companies with increasing investments fuel this region's market expansion. In addition, membrane filters are becoming more popular among pharmaceutical businesses due to their advantages over dead-end filters, such as high throughput, high accuracy, and shorter filtration durations.
The Canada Tangential Flow Filtration Market will likely develop significantly due to pharmaceutical company expenditures and a boom in biologics and CMOS manufacturing. Furthermore, factors such as the high availability of money and investments in TFF market research and development boost the Canadian market.
In addition, cutting-edge technologies combined with favorable clinical trials, the mounting of superior automated manufacturing processes, and the increasing adoption of single-use technologies with benefits such as minimizing cross-contamination, increasing flexibility, and reducing process time are expected to drive market growth during the forecast period.
KEY MARKET PLAYERS
Promising Companies leading the North America Tangential Flow Filtration Market Profiled in the Report are GE Healthcare, Sartorius Stedim Biotech S.A, Parker Hannifin Corp, Danaher Corporation, Merck Millipore.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.1 Single-Use Systems
5.1.2 Reusable Systems
5.1.3 Membrane Filters
5.1.4 Filtration Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Membrane Material
5.2.2 Regenerated Cellulose
5.2.3 Other Materials
5.2.4 Y-o-Y Growth Analysis, By Membrane Material
5.2.5 Market Attractiveness Analysis, By Membrane Material
5.2.6 Market Share Analysis, By Membrane Material
5.3.3 Reverse Osmosis
5.3.4 Y-o-Y Growth Analysis, By Technology
5.3.5 Market Attractiveness Analysis, By Technology
5.3.6 Market Share Analysis, By Technology
5.4 Pore Size/MWCO
5.4.3 Reverse Osmosis Filters
5.4.4 Y-o-Y Growth Analysis, By Pore Size/MWCO
5.4.5 Market Attractiveness Analysis, By Pore Size/MWCO
5.4.6 Market Share Analysis, By Pore Size/MWCO
5.5.2 Product Concentration
5.5.3 Purification & Diafiltration
5.5.4 Viral Vectors and Vaccine Purification
5.5.5 Pharmaceutical Water Production
5.5.6 Other Applications
5.5.7 Y-o-Y Growth Analysis, ByApplication
5.5.8 Market Attractiveness Analysis, By Application
5.5.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Membrane Material
18.104.22.168 By Technology
22.214.171.124 By Pore Size
126.96.36.199 By Application
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Membrane Material
18.104.22.168 By Technology
22.214.171.124 By Pore Size
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Membrane Material
18.104.22.168 By Technology
22.214.171.124 By Pore Size
126.96.36.199 By Application
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare (U.S.).
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck Millipore (U.S.)
8.3 Danaher Corporation (U.S.)
8.4 Sartorius Stedim Biotech S.A. (France)
8.5 Parker Hannifin Corporation (U.S.)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.